Unique ID issued by UMIN | UMIN000012565 |
---|---|
Receipt number | R000014698 |
Scientific Title | Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study |
Date of disclosure of the study information | 2014/02/01 |
Last modified on | 2017/07/11 11:44:52 |
Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study
Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study
Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study
Strut Coverage After Paclitaxel-Eluting Stent implantation Compared with Bare Metal Stent Implantation in the Superficial Femoral Artery: Optical Frequency Domain Imaging Study
Japan |
Peripheral Artery Disease (PAD)
Cardiology |
Others
NO
To assess the detailed vascular responses to different stent types in the superficial femoral artery lesions
Efficacy
Confirmatory
Explanatory
Not applicable
The percentage of uncovered stent struts 6 months after stent implantation
Neointimal volume 6 months after stent implantation
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
2
Treatment
Medicine |
Bare-metal nitinol stent implantation for the superficial femoral artery lesion
Paclitaxel-eluting nitinol stent implantation for the superficial femoral artery lesion
20 | years-old | <= |
Not applicable |
Male and Female
Patients planned endovascular therapy with self-expanding stent for the de novo superficial femoral artery lesions (less than 15cm) in Hyogo College of Medicine
1)Lesions with previous stent implantation
2)Lesions with previous FP-bypass
3)Acute or subacute limb ischemia
4)Patients without tolerance for antiplatelet agents
5)Patients without written informed consent
40
1st name | |
Middle name | |
Last name | Tohru Masuyama |
Hyogo College of Medicine
Cardiovascular Division
1-1 Mukogawa-cho, Nishinomiya-city, Hyogo, 6638501, Japan
0798456553
hpxkg043@ybb.ne.jp
1st name | |
Middle name | |
Last name | Kojiro Miki |
Hyogo College of Medicine
Cardiovascular Division
1-1 Mukogawa-cho, Nishinomiya-city, Hyogo, 6638501, Japan
0798456553
hpxkg043@ybb.ne.jp
Cardiovascular Division, Hyogo College of Medicine
Cardiovascular Division, Hyogo College of Medicine
Other
NO
兵庫医科大学病院(兵庫県)
2014 | Year | 02 | Month | 01 | Day |
Published
Completed
2013 | Year | 12 | Month | 10 | Day |
2013 | Year | 12 | Month | 10 | Day |
2014 | Year | 12 | Month | 09 | Day |
2014 | Year | 12 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
2014 | Year | 12 | Month | 31 | Day |
2013 | Year | 12 | Month | 12 | Day |
2017 | Year | 07 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000014698